Get a glimpse into our company and investor data—powered by the PitchBook Platform
Developer of Prosthetic Antigen Receptors. The company develops receptors which uses protein dimerization to produce nanorings that can be used for selective anti-tumor capabilities.
You’re viewing a free company profile from the PitchBook Platform. To explore Tychon Biosciences’s full profile, request a free trial.
© 2019 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.